Share >  
Share
Share on Tumblr

Hcv

News »

   latest by relevance
Commercial vehicle sales to improve in Feb and March 2012
Feb 23, 2012 at 18:29 | Source: Moneycontrol.com
Prabhudas Lilladher has come out with its report on automobiles - commercial vehicle update. According to the research firm, The overall cargo offerings are expected to be buoyant in next couple of months leading to additional demand for fleet replacement and expansion.
Auto ancillaries to cut down on capex by 35%: CRISIL
Feb 02, 2012 at 16:00 | Source: Moneycontrol.com
CRISIL Ratings esearch has come out with its report on auto space. According to the rating agency demand recovery in the M&HCV and passenger car segments is likely to be gradual, due to limited flexibility of the government to stimulate demand.
Two-wheelers, LCVs to drive Q3 auto sales growth up 20-22%
Jan 10, 2012 at 14:54 | Source: Moneycontrol.com
The road so far this fiscal has been full of speed bumps for passenger car makers. But good growth among two-wheelers and light commercial vehicles is expected to drive automobile sector's revenue up 20-22% from a year ago in the third quarter.
Slowdown looming in CV industry as headwinds gain pace:ICRA
Dec 16, 2011 at 11:27 | Source: Moneycontrol.com
ICRA has come out with its quarterly review on Indian commercial vehicle industry for December 2011. As per the research firm slowdown imminent as headwinds gain momentum.
क्षमता विस्तार पर 80 करोड़ रु खर्च करेंगे: सोना कोयो
Aug 27, 2010 at 14:52 | Source:
कंपनी को वित्त वर्ष-11 में आय में 20% बढ़त की उम्मीद है।
Eicher Motors eyes 15% mkt share in HCV segment by 2015
Jun 11, 2010 at 19:15 | Source: CNBC-TV18
Siddhartha Lal, MD and CEO, Eicher Motors, said the company hopes to achieve 15% market share in heavy commercial vehicle segment by 2015. Its current HCV market share stands at 2%.

Videos »
Eicher Motors eyes 15% mkt share in HCV segment by 2015
Falling demand: HCV makers cut production
Hope of 'friendly Budget' may see mkts do well: Centrum Cap
Interest rate cut could benefit autos: Motilal Oswal
Force Motors to hive off HCV div to subsidiary
more »

Photos »

  /  
News across the web »
Truck lane seen slow for some time to come
The slowdown in the heavy-duty commercial vehicle (CV) segment is expected to continue for up to six months. Experts said that sales had peaked in early March when some prospective buyers, encouraged ...
May 23, 2012 at 13:26 | Source: DNA India
Ashok Leyland net down 10 per cent in FY12
Ashok Leyland has posted a 10 per cent reduction in net profit for 2011-12, hit by higher finance cost, increased depreciation and a muted market in its southern strongholds.The Hinduja group's flags...
May 15, 2012 at 13:16 | Source: Business Today
High excise duty dents medium, heavy commercial vehicle sales
Hit by a hike in excise duty, the sales of medium and heavy commercial vehicles (M HCVs) declined by 11.60 per cent last month -- to 19,914 units. While the M HCVs used for passenger transportation gr...
May 11, 2012 at 11:26 | Source: Business Standard
Tata Motors sales down 7 percent in April year-on-year
New Delhi: Automobile major Tata Motors Tuesday reported a decline of 7 percent in its total sales including exports in April which stood at 60,086 units from 64,383 units sold in the corresponding p...
May 03, 2012 at 12:46 | Source: FirstPost
Tata Motors sales down 7 per cent in April, Nano sales slump
Tata Motors has reported a decline of 7 per cent in its total sales including exports in April which stood at 60,086 units from 64,383 units sold in the corresponding period of last year.The company'...
May 01, 2012 at 17:26 | Source: Business Today
more »
Interact & exchange stock tips & market info »

athina

Platinum Member

500 Followers

Span Diagnostic  

Span Diagnostics Ltd. offers simple, user-friendly test kits for diagn...

1.51 PM Mar 23rd

kolaskar

Silver Member

5 Followers

Tata Motors  

TATA motors had had a great run from 138 to almost 300 in a span of le...

4.42 PM Mar 16th

akhil29sep

Silver Member

1 Followers

Tata Motors  

market were 51,872 nos., a 26% growth, compared to 41,130 vehicles, s...

12.22 PM Mar 13th

Related News »
OraSure Technologies Applauds CDC Proposed Draft Guidelines for Testing of Baby Boomers for Hepatitis C
They estimate that more than 2 million U.S. baby boomers are infected with HCV and are five times more likely to be infected than other adults. Hepatitis C causes serious liver diseases including liver cancer, which is the fastest-rising cause ...
May 29, 2012 at 12:17 | Source: Yahoo Finance
Achillion Announces Additional Proof-of-Concept Data With ACH-2684 for the Treatment of Hepatitis C
Achieves Up to 3.73 log10 Reduction in Genotype 1 HCV RNA After Three Days of Treatment With Once-Daily 400 mg ACH-2684 in Phase 1b Study NEW HAVEN, Conn., May 21, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN ...
May 21, 2012 at 11:00 | Source: NASDAQ
Hepatitis C Virus and the Brain
Hepatitis C virus (HCV) is an enveloped, positive-strand RNA virus of the family Flaviviridae that primarily infects hepatocytes, causing acute and chronic liver disease. HCV is also associated with a variety of extrahepatic symptoms including ...
May 21, 2012 at 10:03 | Source: Medscape News
Complications Are Emerging for Baby Boomers With HCV
May 19, 2012 (San Diego, California) — An analysis of claims data from 2008 shows that the majority of people infected with hepatitis C virus (HCV) are 45 to 64 years of age (i.e., the "baby boomer" generation), and that a significant proportion of ...
May 19, 2012 at 15:06 | Source: Medscape News
OraSure Technologies Announces Rapid HCV Testing Initiatives for First National Hepatitis Testing Day
BETHLEHEM, Pa., May 18, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR - News) today announced its support of numerous rapid hepatitis C (HCV) testing initiatives for the first National Hepatitis Testing Day, taking place on ...
May 29, 2012 at 10:37 | Source: Yahoo Finance
Achillion receives fast track designation from FDA for HCV treatment
May 17, 2012 (Datamonitor via COMTEX) -- Achillion Pharmaceuticals, Inc., a biopharmaceutical company, has received fast track designation from the FDA for ACH-3102 as part of an interferon-free regimen for the treatment of chronic hepatitis C ...
May 17, 2012 at 20:31 | Source: TMCnet
Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe
Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious ...
May 15, 2012 at 12:05 | Source: News-Medical.Net
ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
ACH-3102 is a pan-genotypic second-generation NS5A inhibitor against HCV that was discovered by Achillion and is currently being evaluated in a Phase 1 clinical trial. Fast Track designation was requested for ACH-3102 for its potential to ...
May 15, 2012 at 11:00 | Source: NASDAQ
RNCOS Releases a New Report - India MCV and HCV Market Outlook
Noida, UP -- (SBWIRE) -- 05/21/2012 -- RNCOS has recently added a new Market Research Report titled, “India MCV and HCV Market Outlook” to its report gallery. India opened its doors for multinational automobile companies 20 years ago.
May 21, 2012 at 13:59 | Source: SBWire
Project ECHO: Bringing Medical Specialists Together to Discuss New HCV Therapies to Treat HCV
Project ECHO™, University of New Mexico Office of Continuing Education, and Consensus Medical Communications are pleased to announce the annual Project ECHO™: Knowledge Networks for New HCV Therapies live teleconference continuing medical education ...
May 22, 2012 at 06:34 | Source: PRWeb

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window